Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Complete remission following donor PBSC after low-dose cytarabine chemotherapy for early relapse of acute myelogenous leukemia after allogeneic stem cell transplantation

Bone Marrow Transplantation volume 19, pages 381–383 (1997)Cite this article

Abstract

A 55-year-old woman with chemotherapy-resistant acute myeloblastic leukemia (AML M2) relapsed 3 months after allogeneic PBSC transplant. The patient was treated with two cycles of low-dose cytarabine chemotherapy followed by G-CSF mobilized donor PBSC after cessation of all immunosuppressive treatment. Hematological and cytogenetic complete remission was observed after the first cycle. The patient had been previously treated for AGVHD after allogeneic PBSC transplantation and experienced a second AGVHD after the second cycles of cytoreductive treatment and donor PBSC infusion. Hematological recovery after donor PBSC infusion was faster than recovery after previous chemotherapy or high-dose chemotherapy. During treatment no febrile neutropenia was observed. This case shows that donor PBSC infusion cannot only provide prolonged complete hematological and cytogenetic remission but also seems to support accelerated hematopoietic recovery for some patients relapsing after allogeneic BMT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Institut J Bordet, Service de Médecine Interne et Laboratoire d’Investigation, Clinique H Tagnon, Brussels, Belgium

    R Trenschel, M Bernier, P Stryckmans, A Verhest, R Badjou, P Crombez & D Bron

Authors
  1. R Trenschel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Bernier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P Stryckmans
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Verhest
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R Badjou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P Crombez
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D Bron
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trenschel, R., Bernier, M., Stryckmans, P. et al. Complete remission following donor PBSC after low-dose cytarabine chemotherapy for early relapse of acute myelogenous leukemia after allogeneic stem cell transplantation. Bone Marrow Transplant 19, 381–383 (1997). https://doi.org/10.1038/sj.bmt.1700668

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1700668

Keywords

Search

Advanced search

Quick links